Executive Summary
- •EliseAI raised $350M at a $4B valuation to expand its property and healthcare automation platforms.
- •Annual recurring revenue climbed past $200M by mid-2026 after crossing $100M earlier in 2025.
- •Co-led by a16z and Bessemer, the round targets administrative overhead across housing and clinical workflows.
Community Sentiment
Key Developments & Data
EliseAI secured $350M in fresh funding at a $4B valuation, nearly doubling its previous $2.2B valuation from roughly 13 months ago.
The company saw its annual recurring revenue surpass $100M earlier in 2025 before climbing past $200M by mid-2026.
The round was co-led by repeat investors Andreessen Horowitz and Bessemer Venture Partners, alongside new participant Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital.
EliseAI expanded its automation software from multifamily housing leases and maintenance into healthcare intake and scheduling workflows.
Headcount scaled from around 150 employees after its August 2024 Series D round to more than 300 by mid-2025.
Zubiqo Intelligence Briefing
Get the unfiltered signal before markets open.
Top tech breakthroughs, venture funding, and market moves—synthesized into a 2-minute morning read. Zero PR fluff.
✓ 100% Free•✓ 1-click unsubscribe•✓ No spam ever
Zubiqo Strategic Assessment
Primary Impact
Multifamily real estate property managers and US healthcare administration departments handling operational intake and scheduling.
Strategic Shift
Enterprise capital allocation shifting toward practical vertical workflow automation over generic foundational model development.
The Ripple Effect
Legacy healthcare and property management software vendors will face aggressive pricing pressure to acquire or match vertical AI automation startups.
This intelligence assessment is generated by Zubiqo's AI for informational purposes only.
Intelligence Quality Rating
Grade this brief: Slide & release to submit rating, or tap a preset.
🔥High Impact75%
Slide & release to voteImmune to accidental scroll
